US2012230957A1PendingUtilityA1
Compositions and methods for treatment of pain
Est. expiryMar 9, 2031(~4.7 yrs left)· nominal 20-yr term from priority
A61P 31/00A61P 29/00C12N 1/20A61K 2035/115A61K 35/741A61P 25/00C12R 2001/19C12N 1/205Y02A50/30
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides compositions and methods for treatment or prevention of pain resulting from infection, infection related pain, and non-infectious pain as well as treatment or prevention of infections or adverse health consequences associated with infections.
Claims
exact text as granted — not AI-modified1 . A method for treatment or prevention of pain comprising administering a probiotic composition to a subject having pelvic pain.
2 . The method of claim 1 , wherein said pain is due to an active or inactive urinary tract infection.
3 . The method of claim 1 , wherein said subject has previously been diagnosed with a urinary tract infection.
4 . The method of claim 1 , wherein said probiotic compositions comprise probiotic bacteria.
5 . The method of claim 1 , wherein said probiotic compositions comprise compositions derived from probiotic bacteria.
6 . The method of claim 1 , wherein probiotic compositions comprise LPS.
7 . The method of claim 4 , wherein said probiotic composition an asymptomatic E. coli strain isolated from the human urinary tract.
8 . The method of claim 7 , wherein said probiotic composition comprises a strain of E. coli selected from the group consisting of NUA2, NUA1, 2-21, 2-37, 2-35, 2-32, 2-13, 2-29, 2-42, 2-44, 2-8, 2-43, NUA3, 83972, 2-33 and 2-12.
9 . The method of claim 8 , wherein said probiotic bacteria comprises E. coli strain 83972 or a bacteria or strain that produces a functionally equivalent reduction in pain.
10 . The method of claim 8 , wherein said probiotic bacteria comprises E. coli strain 2-12 or a bacteria or strain that produces a functionally equivalent reduction in pain.
11 . The method of claim 1 , wherein said probiotic composition treats or prevents infection and/or inflammation in addition to pain.
12 . The method of claim 1 , wherein said probiotic composition treats or prevents pain without treating or preventing infection and/or inflammation.
13 . The method of claim 1 , wherein said probiotic composition is administered as a tablet, capsule, pill, injection, cream, ointment, lotion, slave, balm, suppository, solution, elixir, syrup, suspension, cream, lozenge, paste or spray.
14 . The method of claim 1 , wherein said probiotic composition is administered systemically.
15 . The method of claim 1 , wherein said probiotic composition is administered locally to the region of infection and/or pain.
16 . The method of claim 13 , wherein said probiotic composition is administered vaginally.
17 . The method of claim 1 , wherein said probiotic composition is administered such that pain in the affected region of infection and/or pain is treated via organ crosstalk or via corresponding dermatomes.
18 . The method of claim 1 , wherein said pain is non-infectious pain.
19 . The method of claim 18 , wherein said non-infectious pain is acute non-infectious pain or chronic non-infectious pain.
20 . The method of claim 3 , wherein said probiotic composition treats symptoms of a urinary tract infection.
21 . A composition comprising a probiotic composition formulated for treating pelvic pain.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.